Virginia Wealth Management Group Inc. lessened its stake in shares of JPMorgan Chase & Co. (NYSE:JPM – Free Report) by 8.2% in the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 23,753 shares of the financial services provider’s stock after selling 2,129 shares during the quarter. JPMorgan Chase & Co. accounts for about 3.6% of Virginia Wealth Management Group Inc.’s investment portfolio, making the stock its 2nd largest position. Virginia Wealth Management Group Inc.’s holdings in JPMorgan Chase & Co. were worth $5,827,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
Other institutional investors have also bought and sold shares of the company. Mainsail Financial Group LLC lifted its holdings in JPMorgan Chase & Co. by 4.0% during the 1st quarter. Mainsail Financial Group LLC now owns 4,572 shares of the financial services provider’s stock valued at $1,122,000 after purchasing an additional 175 shares during the last quarter. Ironwood Wealth Management LLC. grew its stake in JPMorgan Chase & Co. by 0.7% during the first quarter. Ironwood Wealth Management LLC. now owns 15,400 shares of the financial services provider’s stock worth $3,778,000 after buying an additional 107 shares during the last quarter. Focus Financial Network Inc. increased its holdings in shares of JPMorgan Chase & Co. by 0.7% during the first quarter. Focus Financial Network Inc. now owns 34,971 shares of the financial services provider’s stock worth $8,578,000 after buying an additional 234 shares in the last quarter. Donaldson Capital Management LLC raised its stake in shares of JPMorgan Chase & Co. by 0.8% in the first quarter. Donaldson Capital Management LLC now owns 344,604 shares of the financial services provider’s stock valued at $84,531,000 after acquiring an additional 2,580 shares during the last quarter. Finally, Foresight Capital Management Advisors Inc. acquired a new position in shares of JPMorgan Chase & Co. in the 1st quarter worth approximately $435,000. Institutional investors and hedge funds own 71.55% of the company’s stock.
JPMorgan Chase & Co. Stock Down 0.0%
Shares of JPMorgan Chase & Co. stock opened at $268.05 on Friday. The business has a fifty day simple moving average of $251.13 and a 200 day simple moving average of $250.46. The stock has a market cap of $744.94 billion, a PE ratio of 13.58, a price-to-earnings-growth ratio of 2.83 and a beta of 1.08. The company has a quick ratio of 0.89, a current ratio of 0.88 and a debt-to-equity ratio of 1.24. JPMorgan Chase & Co. has a 12 month low of $190.88 and a 12 month high of $280.25.
JPMorgan Chase & Co. Dividend Announcement
The company also recently announced a quarterly dividend, which will be paid on Thursday, July 31st. Shareholders of record on Thursday, July 3rd will be issued a $1.40 dividend. The ex-dividend date is Thursday, July 3rd. This represents a $5.60 annualized dividend and a yield of 2.09%. JPMorgan Chase & Co.’s dividend payout ratio (DPR) is presently 27.49%.
Insiders Place Their Bets
In other JPMorgan Chase & Co. news, COO Jennifer Piepszak sold 6,128 shares of the stock in a transaction dated Thursday, June 5th. The stock was sold at an average price of $262.47, for a total value of $1,608,416.16. Following the completion of the sale, the chief operating officer now directly owns 62,455 shares in the company, valued at $16,392,563.85. This represents a 8.94% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, CEO Troy L. Rohrbaugh sold 25,000 shares of JPMorgan Chase & Co. stock in a transaction dated Monday, March 24th. The shares were sold at an average price of $247.02, for a total value of $6,175,500.00. Following the transaction, the chief executive officer now owns 133,381 shares in the company, valued at $32,947,774.62. This trade represents a 15.78% decrease in their position. The disclosure for this sale can be found here. Over the last three months, insiders have sold 101,722 shares of company stock worth $25,599,477. Company insiders own 0.47% of the company’s stock.
Analyst Ratings Changes
A number of research firms recently weighed in on JPM. Truist Financial raised their price target on JPMorgan Chase & Co. from $270.00 to $280.00 and gave the company a “hold” rating in a report on Monday, June 2nd. Wall Street Zen upgraded JPMorgan Chase & Co. from a “sell” rating to a “hold” rating in a research note on Wednesday, May 14th. Cowen reaffirmed a “buy” rating on shares of JPMorgan Chase & Co. in a report on Tuesday, May 20th. Evercore ISI decreased their price objective on shares of JPMorgan Chase & Co. from $273.00 to $265.00 and set an “outperform” rating on the stock in a report on Tuesday, April 1st. Finally, Baird R W raised shares of JPMorgan Chase & Co. from a “strong sell” rating to a “hold” rating in a research note on Friday, March 7th. Thirteen investment analysts have rated the stock with a hold rating and eleven have issued a buy rating to the company’s stock. According to MarketBeat, the company currently has an average rating of “Hold” and an average price target of $269.65.
View Our Latest Stock Report on JPM
JPMorgan Chase & Co. Profile
JPMorgan Chase & Co is a financial holding company, which engages in the provision of financial and investment banking services. It focuses on investment banking, financial services for consumers and small businesses, commercial banking, financial transaction processing, and asset management. It operates through the following segments: Consumer and Community Banking (CCB), Commercial and Investment Bank (CIB), Asset and Wealth Management (AWM), and Corporate.
Featured Articles
- Five stocks we like better than JPMorgan Chase & Co.
- Market Cap Calculator: How to Calculate Market Cap
- Ignore the Noise—Samsara Stock Is Still a Strong Buy
- There Are Different Types of Stock To Invest In
- 3 Stocks Set to Double—And There’s Still Time to Buy
- How Investors Can Find the Best Cheap Dividend Stocks
- Analysts Can’t Get Enough of These Little-Known Biopharma Stocks
Receive News & Ratings for JPMorgan Chase & Co. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for JPMorgan Chase & Co. and related companies with MarketBeat.com's FREE daily email newsletter.